New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A potential therapy to reduce the side effects of chemotherapy

A potential therapy to reduce the side effects of chemotherapy

byInstitut National de la Sante et de la Recherche MedicaleGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI152924Cisplatin is a chemotherapy indic
Oncology December 26,2023
A potential therapy to reduce the side effects of chemotherapy

A potential therapy to reduce the side effects of chemotherapy

byInstitut National de la Sante et de la Recherche MedicaleGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI152924Cisplatin is a chemotherapy indic
Oncology December 26,2023
New hope for reduced long-term side effects in children after leukemia treatment

New hope for reduced long-term side effects in children after leukemia treatment

byUniversity of OsloResearcher Nina Richartz at the Department of Molecular Medicine at the University of Oslo. Credit: Cecilie Bakken Hostmark, UiOBy using drugs currently used to treat other d
Pediatrics December 26,2023
New hope for reduced long-term side effects in children after leukemia treatment

New hope for reduced long-term side effects in children after leukemia treatment

byUniversity of OsloResearcher Nina Richartz at the Department of Molecular Medicine at the University of Oslo. Credit: Cecilie Bakken Hostmark, UiOBy using drugs currently used to treat other d
Pediatrics December 26,2023
Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang
Oncology December 25,2023
Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang
Oncology December 25,2023
CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece
Oncology December 25,2023
CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece
Oncology December 25,2023
Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),
Oncology December 25,2023
Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),
Oncology December 25,2023
Novel therapeutic target for acute myeloid leukemia

Novel therapeutic target for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainNorthwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell p
Oncology December 25,2023
Novel therapeutic target for acute myeloid leukemia

Novel therapeutic target for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainNorthwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell p
Oncology December 25,2023
Even moderate exercise linked to reduced mortality after breast cancer

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie
Oncology December 25,2023
Even moderate exercise linked to reduced mortality after breast cancer

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie
Oncology December 25,2023
Point-of-care biosensor rapidly detects oral cancer

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin
Oncology December 25,2023
Point-of-care biosensor rapidly detects oral cancer

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin
Oncology December 25,2023
Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu
Oncology December 25,2023
Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu
Oncology December 25,2023
Timely surveillance with chest imaging may benefit colorectal cancer patients

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may
Oncology December 25,2023
Timely surveillance with chest imaging may benefit colorectal cancer patients

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may
Oncology December 25,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com